Literature DB >> 21974805

Galectin-3--a jack-of-all-trades in cancer.

Anna U Newlaczyl1, Lu-Gang Yu.   

Abstract

Galectin-3 is a mammalian β-galactoside-binding protein that is expressed by various types of human cells. Changes in galectin-3 expression and subcellular and intercellular localizations are commonly seen in cancer and pre-cancerous conditions. It is increasingly recognized that galectin-3 is an important regulator of a broad range of cancer cell activities and plays important roles in cancer cell growth, transformation, apoptosis, angiogenesis, adhesion, invasion and metastasis. Such a divergent influence of galectin-3 on cancer cell activities derives from its multiple inter- and sub-cellular localizations where it interacts with a range of different binding partners. This mini-review summaries the diverse influences of galectin-3 on cancer cell behaviours with particular emphasis on its role in tumorigenesis and metastasis.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21974805     DOI: 10.1016/j.canlet.2011.09.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  134 in total

1.  Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome.

Authors:  Debraj GuhaThakurta; Nadeem A Sheikh; Li-Qun Fan; Harini Kandadi; T Craig Meagher; Simon J Hall; Philip W Kantoff; Celestia S Higano; Eric J Small; Thomas A Gardner; Kate Bailey; Tuyen Vu; Todd DeVries; James B Whitmore; Mark W Frohlich; James B Trager; Charles G Drake
Journal:  Clin Cancer Res       Date:  2015-02-03       Impact factor: 12.531

2.  Role of MSC-derived galectin 3 in the AML microenvironment.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Jared K Burks; YiHua Qiu; Rui-Yu Wang; Elizabeth J Shpall; Leonardo Mirandola; Numsen Hail; Zhihong Zeng; Teresa McQueen; Naval Daver; Sean M Post; Maurizio Chiriva-Internati; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-04-12       Impact factor: 4.739

3.  Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.

Authors:  Guoqing Cai; Xiangdong Ma; Biliang Chen; Yanhong Huang; Shujuan Liu; Hong Yang; Wei Zou
Journal:  Tumour Biol       Date:  2016-04-08

4.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman
Journal:  Antioxid Redox Signal       Date:  2019-03-29       Impact factor: 8.401

Review 5.  Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.

Authors:  Joel G Turner; Jana Dawson; Christopher L Cubitt; Rachid Baz; Daniel M Sullivan
Journal:  Semin Cancer Biol       Date:  2014-03-12       Impact factor: 15.707

6.  Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer.

Authors:  Sayaka Yamaki; Takaaki Fujii; Reina Yajima; Tomoko Hirakata; Satoru Yamaguchi; Tomomi Fujisawa; Soichi Tsutsumi; Takayuki Asao; Yasuhiro Yanagita; Misa Iijima; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2012-10-23       Impact factor: 2.549

7.  The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer.

Authors:  Daniel P Hollern; Jordan Honeysett; Robert D Cardiff; Eran R Andrechek
Journal:  Mol Cell Biol       Date:  2014-06-16       Impact factor: 4.272

8.  Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling.

Authors:  Umadevi V Wesley; Raghu Vemuganti; Emine R Ayvaci; Robert J Dempsey
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

9.  Relationship of galectin-3 with obesity, IL-6, and CRP in women.

Authors:  J Pang; V T Nguyen; D H Rhodes; M E Sullivan; C Braunschweig; G Fantuzzi
Journal:  J Endocrinol Invest       Date:  2016-07-21       Impact factor: 4.256

10.  Association between circulating galectin-3 levels and the immunological, inflammatory and nutritional parameters in patients with colorectal cancer.

Authors:  Tatsuo Shimura; Masahiko Shibata; Kenji Gonda; Takahiro Nakajima; Shun Chida; Masaru Noda; Satoshi Suzuki; Izumi Nakamura; Shinji Ohki; Seiichi Takenoshita
Journal:  Biomed Rep       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.